USEC, Inc. (USU) Moves Higher, This Time on Additional Funding Agreement
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
USEC (USU), Unit Enters Amended RD&D with DoE; Receives $29.9M of Additional Funding
July 29, 2013 8:07 AM EDTThe research, development and demonstration (RD&D) program to advance USEC Inc.s (NYSE: USU) American Centrifuge, Americas next generation of uranium enrichment technology, continues to make solid progress in completing program milestones.
Five of the programs nine milestones have been completed and certified by the Department of Energy (DOE). USEC successfully completed the sixth milestone to test the effects of a power loss to the uranium centrifuge machines earlier this month, and DOE certification of that milestone is pending. The three remaining milestones are scheduled for completion by the end of... More
Unusual 11 Mid-Day Movers 07/26: (GENT) (USU) (ETRM) Higher; (HTCH) (EXPE) (SWI) Lower
July 26, 2013 1:19 PM EDTGentium S.p.A. (Nasdaq: GENT) 61.4% HIGHER; announced that, following its request for re-examination, the European Medicines Agency's Committee for Medicinal Products for Human Use adopted a positive opinion for Defitelio recommending a Marketing Authorization Application ("MAA") under exceptional circumstances, for the treatment of severe hepatic veno-occlusive disease in adults and children undergoing hematopoietic stem cell transplantation therapy.
USEC Inc. (NYSE: USU) 51.4% HIGHER; USEC making another strong move today. Shares are up over 260... More
USEC (USU) Rips Apart Shorts, Shares Up ~260% Over Last Week
July 26, 2013 12:25 PM EDTUSEC Inc. (NYSE: USU) is obliterating any shorts left on the stock.
After a strong run earlier this week, shares of the uranium refiner are up over 50 percent again today. Speculation surrounds a positive outcome for restarting nuclear plants in Japan following last... More
